Research review
Does milk thistle help with cancer? What the research does and doesn't show
The evidence doesn't support milk thistle as a cancer treatment or preventive. The human research that exists tested it as an add-on during chemotherapy, to see if it reduces treatment side effects like liver toxicity or diarrhea — not to treat the cancer itself.
The evidence doesn't support milk thistle as a cancer treatment, prevention, or alternative to chemotherapy or radiation — no trial has tested it that way. What exists instead is a small set of trials in people already diagnosed with cancer and already undergoing chemotherapy, testing whether silymarin lessens the chemotherapy's side effects. The results on side effects are mixed but somewhat encouraging; neither trial measured the cancer itself.
What the evidence doesn't support
It doesn't support milk thistle as something that shrinks a tumor, slows cancer progression, extends survival, or replaces any part of a standard cancer treatment plan. It doesn't support use for prostate cancer specifically — we found no human trial testing that. Every trial below enrolled people who were already diagnosed with cancer and already receiving chemotherapy under an oncology team's care; none of it tested milk thistle as a preventive in a cancer-free population, and it doesn't describe a specific brand's dose or product.
What the trials found
A randomized, placebo-controlled trial gave 30 people with non-metastatic breast cancer, all receiving a doxorubicin-based chemotherapy regimen (AC-T), either 420 mg/day of oral silymarin or placebo for one month, to see whether it would reduce chemotherapy-related liver damage. Liver involvement graded by ultrasound was significantly lower in the silymarin group after treatment, but blood-based liver function tests didn't differ significantly between the two groups — a mixed result across the different ways the trial measured liver injury.
A separate pilot trial gave silymarin (450 mg/day, for 7 days of each treatment cycle) to 70 people with metastatic colorectal cancer receiving a different chemotherapy regimen, FOLFIRI plus bevacizumab, to see whether it would reduce common side effects. The silymarin group had significantly less diarrhea and nausea than the group on chemotherapy alone, though there was no difference in liver toxicity between the two groups — the opposite pattern of side effect measured than the breast cancer trial above.
Both trials were designed and reported as chemotherapy-tolerability studies, not cancer-outcome studies: neither measured tumor size, cancer progression, or survival, and neither trial used silymarin as an alternative to chemotherapy — it was given alongside the standard regimen in both cases.
| Trial | Population | Dose | What it measured |
|---|---|---|---|
| Moezian 2021 (n=30) | Breast cancer on AC-T chemotherapy | 420 mg/day, 1 month | Less liver damage on ultrasound; no difference on liver blood tests |
| Chang 2021 (n=70) | Metastatic colorectal cancer on FOLFIRI + bevacizumab | 450 mg/day, 7 days per cycle | Less diarrhea and nausea; no difference in liver toxicity |
Questions people ask
Can cancer patients take milk thistle?
The trials above gave silymarin to cancer patients already receiving chemotherapy, with generally acceptable safety and some reduction in specific side effects. But that's a decision for an oncology team, not a self-directed one — see "when to talk to a doctor" below, since some supplements can interact with specific chemotherapy drugs.
Does milk thistle help with breast cancer or prostate cancer?
The one breast cancer trial we found tested silymarin's effect on chemotherapy-related liver damage, not on the cancer itself, with mixed results depending on how liver injury was measured. We found no human trial testing milk thistle for prostate cancer.
Does milk thistle help during chemotherapy?
Two small trials found it reduced specific chemotherapy side effects — liver-damage severity in one, diarrhea and nausea in the other — when taken alongside the chemotherapy regimen, not instead of it. Results varied by which side effect each trial measured.
When to talk to a doctor
Milk thistle is not a cancer treatment, and anyone with a cancer diagnosis should make any supplement decision with their oncology team, since some herbal products can interact with specific chemotherapy drugs in ways that aren't fully mapped. Don't start, stop, or add milk thistle during cancer treatment without checking with the team managing that treatment first.
Related reading: milk thistle and medications: what to check, milk thistle side effects, and who should not take milk thistle.
Sources
- Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial A small trial in 30 breast cancer patients on chemotherapy found 420 mg/day of silymarin, taken alongside the chemo regimen, reduced liver damage severity on ultrasound after one month, though blood-based liver function tests showed no significant difference between groups.
- A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab A pilot trial in 70 colorectal cancer patients found silymarin taken alongside chemotherapy was associated with less diarrhea and nausea than chemotherapy alone, with no difference in liver toxicity between groups.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.